Select Page

Aurobindo Pharma Share Price Target for 2024, 2025, 2030, and 2040

Aurobindo Pharma Share Price Target for 2024, 2025, 2030, and 2040

In this post, we will discuss the Aurobindo Pharma share price target for the upcoming years. The pharmaceutical industry has emerged as a profitable investment since the COVID pandemic. The last decade saw dramatic growth in the pharmaceutical industry with the adoption of new therapies, the emergence of biosimilars, increased demand for specialty drugs, and improvements in healthcare access and affordability. One of the industries with the most regulations is the pharmaceutical sector. To generate top-notch solutions for the demands of patients all around the world, the corporations are consistently improving their research and development capabilities. Aurobindo Pharma is dedicated to being one of the pharmaceutical industry’s most sustainable businesses.

About Aurobindo Pharma Ltd.

Aurobindo Pharma Limited is the second-largest Indian multinational pharmaceutical manufacturing company, incorporated in 1986. It is a large-cap company with a market capitalization of  ₹ 50,253.02 crore. It is the largest generics company in the US (by Rx dispensed) and among the top 10 generics companies in six out of nine countries in Europe. The company exports to more than 150 countries, and over 90% of its revenue comes from exports.

Company NameAurobindo Pharma Ltd.

Key Metrics

Market Cap (₹)50,253.02 Crore
Sectoral Market Cap Rank9
PE Ratio (x)25.42
Price to Book Ratio (x)1.79
EPS – TTM (₹)33.75
Dividend Yield (%)0.35
Stock – 52 Week High & Low (₹)887.70 / 397.20

Contribution in total revenue (%) of Aurobindo Pharma Ltd.

Aurobindo Pharma’s share price forecasts for 2024, 2025, 2030, and 2040 are shown in the table below.

YearMinimum PriceMaximum Price
2023₹ 870
2024₹ 865₹ 950
2025₹ 950₹ 1,060
2026₹ 1,050₹ 1,220
2027₹ 1,210₹ 1,340
2028₹ 1,350₹ 1,500
2029₹ 1,480₹ 1,650
2030₹ 1,650₹ 1,850
2040₹ 3,850₹ 4,200

Important Note: These price targets of “Aurobindo Pharma Limited” are only for reference purpose only, short-term and long-term Aurobindo Pharma Limited stock price predictions may be different due to the different analyzed time series. This prediction is only if there are positive market sentiments, and any uncertainties in the company or global market condition is not covered in this analysis. 

Aurobindo Pharma Share Price Target for 2023

After the COVID pandemic, the pharmaceutical industry has emerged as a major growth driver in the country or across the world. Pharmaceutical companies have also done well this year. According to our forecast, the company’s share price may reach ₹ 870 by the end of this year.

YearMinimum PriceMaximum Price
2023₹ 870

Aurobindo Pharma Share Price Target for 2024

The company is building a diversified portfolio of finished dosage forms in orals, liquids, topicals, biosimilars, nasals, and parenteral products targeted at global markets, and in the previous financial year, the company’s primary R&D focus was complex parenteral products. The company’s long-term goal envisions a shift to a higher mix of branded products within the categories where it has a dominant presence. If we analyze the share price of the coming year, the minimum price will be ₹ 865 and the maximum price will be ₹ 950.

YearMinimum PriceMaximum Price
2024₹ 865₹ 950

Aurobindo Pharma Share Price Target for 2025

Aurobindo Pharma has planned to make an array of distinctive brands that will enable the company to make its own space and shift from the crowded generics market with a better command over profitability and user segments. The company’s new product development capability, along with its manufacturing flexibility and very large geographic presence, would act as force multipliers.

YearMinimum PriceMaximum Price
2025₹ 950₹ 1,060

Aurobindo Pharma Share Price Target for 2026

By 2026, the global pharmaceutical market is expected to grow at a rate of 3-6%, reaching approximately $ 1.8 trillion. Demand for over-the-counter (OTC) medicines, generics, and branded pharmaceutical products will rise in many developed and developing countries due to an aging population. Demand for chronic disease treatments, in particular, will rise in the medium and long term. 

Oncology and immunology are expected to grow at a CAGR of 9-12% and 6-9% by 2026, respectively, driven by significant increases in new treatments and medicine use. And Globally, incremental savings from biosimilars are expected to reach $ 215 billion by 2026. Over the next five years, 300 new medicines are expected to be launched, contributing $196 billion in spending.

YearMinimum PriceMaximum Price
2026₹ 1,050₹ 1,220

Aurobindo Pharma Share Price Target for 2027

Greater access to healthcare and medications, as well as increased disposable household incomes, is expected to boost pharmaceutical consumption in emerging markets. Initially, generic and over-the-counter medicine suppliers will benefit from these trends. Aurobindo Pharma will benefit from this as a major player this semester. If we analyze the share price of this year, the minimum price will be ₹1,210 and the maximum price will be ₹ 1,340.

YearMinimum PriceMaximum Price
2027₹ 1,210₹ 1,340


Dr. Reddy’s Laboratories Ltd. Share Price Target 2023, 2024, 2025, 2026, 2028 and 2030

Incorporated in 1984. Dr. Reddy’s Laboratories Limited is a leading Indian pharmaceutical company manufactures and markets a wide range of pharmaceuticals in India and abroad. READ MORE

Aurobindo Pharma Share Price Target for 2028

Aurobindo Pharma Limited has a very strong presence in the US market, which accounts for almost half of its manufacturing revenue and has the largest number of manufacturing facilities outside India. However, this business was one of the hardest hit this year due to increased competition on the pricing of formulations and an unprecedented rise in input materials. Aurobindo’s stock is also not doing well, but it is not permanent. If we talk about this year’s share price, the minimum price will be ₹ 1,350 and the maximum price will be ₹ 1,050.

YearMinimum PriceMaximum Price
2028₹ 1,350₹ 1,050

Aurobindo Pharma Share Price Target for 2029

Aurobindo Pharma has been consistently growing its presence in the China market, which is not only one of the largest healthcare markets in the world but also a dominant supply base. The company is creating an oral formulation facility in China and plans to fulfill its international demand apart from its domestic contribution. Aurobindo Pharma Limited began local manufacturing in China. The company also intends to transfer a few products from Europe to the China facility. If Aurobindo Pharma Ltd. is successful in realizing its plans, there should be significant accretion to both its topline and bottom line spreads.

YearMinimum PriceMaximum Price
2030₹ 1,480₹ 1,650

Aurobindo Pharma Share Price Target for 2030

On the other hand, if we look at the company’s European business, it grew at a steady pace of around 10 to 15 percent, as did its growth markets in countries like Canada and Brazil. The company has completed the development of its injectable manufacturing facility in the US and expects significant growth in demand from that region in the coming years. Biosimilars will continue to grow rapidly at a CAGR of 15% over the next decade, reaching $ 75 billion by 2030. The growth will be driven by the rise of branded medicines and the aggressive measures by governments to reduce healthcare expenditure. In 2030, it is predicted that the stock will show higher growth at that time.

YearMinimum PriceMaximum Price
2040₹ 1,650₹ 1,850

Aurobindo Pharma Share Price Target for 2040

Two sectors will have a bright future with human development: technology and pharmaceuticals. According to experts, the danger of an epidemic like Covid will remain in the near future as well. Aurobindo Pharma has already invested in research and development for the future. The company will have many opportunities in the future, and it is expected that Aurobindo Pharma will take advantage of them.

The company has been consistently working on the opportunities made available by the government’s Production Linked Incentive (PLI) scheme, with penicillin and related areas offering some very appealing prospects. Aurobindo Pharma Ltd. has initiated building capacities in these areas and invested ₹ 2,677.7 million this year. The total capital for this project is expected to be around ₹ 18,500 million to ₹ 19,000 million, which will help to significantly enhance company backward integration, make the production value chain more resilient, and improve control over costs and sustainable profit margins. If we talk about this year’s share price, the minimum price will be ₹ 3,850 and the maximum price will be ₹ 4,200.

YearMinimum PriceMaximum Price
2050₹ 3,850₹ 4,200

Recommendations: Invest in Aurobindo’s stock or sell it?

Our forecasted stock analyst implies that there will be a positive trend in the future and that Aurobindo Pharma shares might be good for investing to make money. If you are good with personal finance and are looking to invest, you can invest in this stock.

Leave a reply

Your email address will not be published. Required fields are marked *

Current IPO (Main Board)

Issuer CompanyOpenClose
Tata Technologies Ltd.--
Plaza Wires Ltd.29-Sep-234-Oct-23
Updater Services Ltd.25-Sep-2327-Sep-23
JSW Infrastructure ltd.25-Sep-2327-Sep-23
Yatra Online Ltd.15-Sep-2320-Sep-23


Issuer CompanyOpenClose
Rajgor Castor Derivatives Ltd.17-Oct-2320-Oct-23
WomanCart Ltd.16-Oct-2318-Oct-23
Committed Cargo Care Ltd.6-Oct-2310-Oct-23
Karnika Industries Ltd.29-Sep-234-Oct-23
Plada Infotech Services Ltd.29-Sep-234-Oct-23
Vivaa Tradecom Ltd.27-Sep-234-Oct-23


No comments to show.